CRT 2024
Innovation
FDA Japan
Session Two [Non-CME]
Madoka Murakami, PhD
Principal ReviewerPharmaceuticals and Medical Devices AgencyChiyoda-ku, Tokyo, Japan
Disclosure(s): No financial relationships to disclose